Cargando…
B-cell receptor-guided delivery of peptide-siRNA complex for B-cell lymphoma therapy
BACKGROUND: Despite the clinical response of conventional anticancer therapy, including chemotherapeutic treatments, radiation therapy and corticosteroids, tumorigenic B-cell lymphomas show an incomplete response to clinical practices that result in a minimal residual disease (MRD) where few residua...
Autores principales: | Migliaccio, Nunzia, Palmieri, Camillo, Ruggiero, Immacolata, Fiume, Giuseppe, Martucci, Nicola M, Scala, Iris, Quinto, Ileana, Scala, Giuseppe, Lamberti, Annalisa, Arcari, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4433068/ https://www.ncbi.nlm.nih.gov/pubmed/25983658 http://dx.doi.org/10.1186/s12935-015-0202-4 |
Ejemplares similares
-
Inhibition of HIV-1 replication in primary human monocytes by the IκB-αS32/36A repressor of NF-κB
por: Palmieri, Camillo, et al.
Publicado: (2004) -
Nanoparticle-based strategy for personalized B-cell lymphoma therapy
por: Martucci, Nicola M, et al.
Publicado: (2016) -
Eukaryotic Initiation Factor 4H Is under Transcriptional Control of p65/NF-κB
por: Fiume, Giuseppe, et al.
Publicado: (2013) -
Human immunodeficiency virus-1 Tat activates NF-κB via physical interaction with IκB-α and p65
por: Fiume, Giuseppe, et al.
Publicado: (2012) -
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43
por: Tuccillo, Franca Maria, et al.
Publicado: (2014)